KALA BIO, Inc. (KALA)
(Delayed Data from NSDQ)
$7.37 USD
+0.29 (4.10%)
Updated Jul 24, 2024 02:59 PM ET
After-Market: $7.13 -0.24 (-3.26%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Brokerage Reports
0 items in cart
KALA BIO, Inc. [KALA]
Reports for Purchase
Showing records 181 - 200 ( 366 total )
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Q2; All Eyes on DED October 30, 2020 PDUFA: We Anticipate Approval
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
2Q20 Results; EYSUVIS Regulatory Decision Approaching; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y